Tamoxifen Metabolism and Breast Cancer Recurrence: A Question Unanswered by CYPTAM

J Clin Oncol. 2019 Aug 1;37(22):1982-1983. doi: 10.1200/JCO.19.00504. Epub 2019 Jun 18.

Authors

Matthew P Goetz¹, Vera J Suman¹, Yusuke Nakamura¹, Kazuma Kiyotani¹, V Craig Jordan¹, James N Ingle¹

Affiliation

¹ Matthew P. Goetz, MD and Vera J. Suman, PhD, Mayo Clinic, Rochester, MN; Yusuke Nakamura, MD, PhD and Kazuma Kiyotani, PhD, Cancer Precision Medicine Center, Tokyo, Japan; V. Craig Jordan, PhD, DSc, The University of Texas MD Anderson Cancer Center, Houston, TX; and James N. Ingle, MD, Mayo Clinic, Rochester, MN.

No abstract available

Publication types

Letter
Comment

MeSH terms

Antineoplastic Agents, Hormonal
Breast Neoplasms*
Humans
Neoplasm Recurrence, Local
Pharmacogenetics
Prospective Studies
Tamoxifen*

Substances

Antineoplastic Agents, Hormonal
Tamoxifen